Key terms

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. The company was founded by Silviu Itescu on June 8, 2004 and is headquartered in Melbourne, Australia.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MESO news

Apr 17 6:58am ET Mesoblast Director Boosts Share Ownership by TipRanks Apr 17 6:58am ET Mesoblast Applies for Quotation of New Shares by TipRanks Apr 17 6:58am ET Mesoblast Issues New Employee Incentive Options by TipRanks Apr 17 6:57am ET Mesoblast Reports Cessation of 80,000 Options by TipRanks Apr 15 8:46am ET Largest borrow rate increases among liquid names by TipRanks Apr 12 8:46am ET Largest borrow rate increases among liquid names by TipRanks Mar 28 10:59am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 21 6:57am ET Mesoblast Limited Announces New Share Issue by TipRanks Mar 14 11:01am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 13 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Mar 12 6:36am ET Mesoblast (MESO) Gets a Hold from Piper Sandler by TipRanks Mar 03 7:16am ET Mesoblast Limited (MEOBF) Receives a Buy from Jefferies by TipRanks Feb 29 7:48am ET Mesoblast (MESO) Gets a Hold from Piper Sandler by TipRanks Feb 14 7:50pm ET FDA grants Mesoblast orphan-drug designation for Revascor by TipRanks Feb 14 2:56pm ET Mesoblast treatment of Hypoplastic Left Heart Syndrome gets orphan status by TipRanks Jan 22 10:57am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 18 6:39pm ET Mesoblast receives RPD designation for Revascor from FDA by TipRanks

No recent press releases are available for MESO

MESO Financials

1-year income & revenue

Key terms

MESO Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MESO Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days
Students at Highlands High School, work on a practice test at the ACT Boot Camp in Newport, Ky.
Patrick Reddy/The Enquirer/AP/File
Private equity finds its next bet: college admissions
In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming